GlobeNewswire

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference 2026 in London
12/11/2026
BOSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Annovis Bio Granted U.S. Patent Covering New Crystalline Form of Buntanetap
12/11/2026
U.S. Patent No. 12,780,831 covers posiphen (buntanetap) D-tartrate Form B, a highly crystalline dihydrate, together with pharmaceutical compositions and methods of preparation, providing protection through 2044 Form B [...]
Rally Report 2026: The momentum is growing. But too many girls are still being left behind
12/11/2026
Canadian Women & Sport's flagship research, with Canadian Tire Jumpstart Charities, finds girls' sport participation has held its gains and points to what it will take to help more girls start and keep playing [...]
Le signal de ralliement 2026 : L’élan prend de l’ampleur, mais trop de filles sont encore laissées en plan
12/11/2026
Réalisée en collaboration avec la Fondation Bon départ de Canadian Tire, la recherche phare de Femmes et sport au Canada révèle que les gains se sont maintenus pour la participation des filles au sport et propose des [...]
Grace Therapeutics Announces Second Quarter 2027 Financial Results, Provides Business Update
12/11/2026
PRINCETON, N.J., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage biopharma company advancing GTx-104, a novel, injectable formulation of [...]
Kamau Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Nula-cel, a Gene-Corrected Stem Cell Therapy for Sickle Cell Disease
12/11/2026
Designation based on preliminary clinical evidence from the Phase 1/2 RESTORE trial; nula-cel also holds Fast Track and Orphan Drug designations SOUTH SAN FRANCISCO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Kamau [...]
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
12/11/2026
Registrational U.S. AURORA Phase 3 clinical trial underway for denifanstat in moderate to severe acne, with topline data anticipated in the second half of 2027 Positive denifanstat Phase 3 clinical trial results in [...]
Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3
12/11/2026
PCAOB audited FY2024 and FY2025 and reviewed unaudited six months ended June 30, 2026 financials of G3 and its consolidated subsidiaries (“G3”) delivered In FY 2025, the Combined G3 company had consolidated revenue of $ [...]
Aclaris Therapeutics to Participate in the Jefferies Global Healthcare Conference
12/11/2026
WAYNE, Pa., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today [...]
Biolojic Design Receives U.S. FDA Clearance of Investigational New Drug (IND) Application for BD200, the First Multibody to Enter Clinical Trials
12/11/2026
BD200 is a multibody drug conjugate, in which each arm of the antibody can alternatively bind to either Nectin-4 or Trop2, two validated oncology antigens that may be expressed on cancer cells Combined with a unique [...]
123Dentist CEO Jeff Leger and family establish fund at Dalhousie University’s Faculty of Dentistry to advance research into the connection between oral health and overall health
12/11/2026
The Leger Family Oral Health Research Fund will back research that deepens understanding of how oral health connects to overall health and chronic disease TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Jeff Leger, Chief [...]
Jeff Leger, président-directeur général de 123Dentiste, et sa famille créent un fonds à la Faculté de médecine dentaire de l’Université Dalhousie pour mieux comprendre le lien entre santé buccodentaire et santé globale
12/11/2026
Le Fonds de recherche en santé buccodentaire de la famille Leger soutiendra des travaux visant à mieux comprendre les liens entre la santé buccodentaire, la santé globale et les maladies chroniques TORONTO, 12 nov. 2026 [...]
Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update
12/11/2026
REVEAL pivotal and ASPIRE trials evaluating TSHA-102 for Rett syndrome ongoing; expect to report topline data from 6-month interim analysis and FDA feedback on BLA submission pathway in 1H 2027 TSHA-102 continues to be [...]
Commit Biologics nominates first development candidate from BiCE™, its complement system engaging platform, and strengthens senior leadership
12/11/2026
COM002 is a first-in-class complement-powered immune engager based on Commit Biologics’ proprietary BiCE™ platform. Anne-Marie Levy Rasmussen appointed Chief Operating Officer and Dr. Benjamin Ole Wolthers as Head of [...]
DaltonTx appoints Melissa Landon as Chief Commercial Officer to drive commercial growth and strategic partnerships
12/11/2026
Dr Landon brings 20+ years of experience in the application of AI/ ML to drug discovery She joins Dalton Tx to drive adoption of Dalton Tx ’s platform across pharma, biotech and CROs LONDON, Nov. 12, 2026 (GLOBE [...]
Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
12/11/2026
~ Third Quarter 2026 Net Product Sales of $19.4 Million, Up 56% Year over Year ~ ~ Third Quarter 2026 Non-GAAP Adjusted EBITDA of $5.8 Million ~ ~ With $6.7 Million in Positive Cash Flow from Operations, Cash Position [...]
Belite Bio Reports Unaudited Third Quarter 2026 Financial Results and Provides a Corporate Update
12/11/2026
New Drug Application (NDA) for tinlarebant in Stargardt disease type 1 (STGD1) granted priority review by the U.S. Food and Drug Administration (FDA) in August 2026 with Prescription Drug User Fee Act (PDUFA) target [...]
Human Appeal USA expands winter coat drive to six states
12/11/2026
Second annual campaign builds on 2,000 coats distributed in Baltimore last year, with plans to engage 40 collection partners and at least 300 volunteers MISSION VIEJO, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Human [...]
Rakovina Therapeutics Expands Strategic Engagement with Renowned AI Drug Discovery Pioneer Dr. Artem Cherkasov
12/11/2026
World leader in AI drug discovery to take on an expanded strategic advisory role, supporting AI drug discovery strategy, technology assessment and corporate development opportunities VANCOUVER, British Columbia, Nov. 12 [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum